| Study characteristics |
| Methods |
Single‐centre, randomised, open‐label trial |
| Participants |
Children 6 to 60 months of age with at least 1 simple FS |
| Interventions |
Oral diazepam 0.33 mg/kg every 8 hours for 2 days or oral clobazam for 2 days dosed by child's weight (daily 5 mg when weight ≤ 5 kg, twice‐daily 5 mg when 6 to 10 kg, twice‐daily 7.5 mg when 11 to 15 kg, twice‐daily 10 mg when > 15 kg) |
| Outcomes |
RS at 12 months and adverse effects |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
High risk |
Randomisation methodology not mentioned. |
| Blinding (performance bias and detection bias)
All outcomes |
High risk |
No blinding |
| Incomplete outcome data (attrition bias)
All outcomes |
High risk |
Not discussed |
| Selective reporting (reporting bias) |
Unclear risk |
Unclear |
| Other bias |
Low risk |
No bias identified. |
| Blinding of participants and personnel (performance bias)
All outcomes |
High risk |
No blinding |
| Blinding of outcome assessment (detection bias)
All outcomes |
High risk |
No blinding |
